<DOC>
	<DOCNO>NCT02701452</DOCNO>
	<brief_summary>In literature , risk moderate severe OHSS 3 6 % reach 31 % high risk population 9 day oocyte trigger hCG . Many study report markedly decrease risk OHSS trigger ovulation GnRH agonist . However , criterion define OHSS rarely explain OHSS thoroughly assert . It well know OHSS associated hypercoagulability . However , study trigger GnRH agonist assess haemostasis high-risk patient high circulate estradiol level . Study design , size , duration : In French academic reproductive medicine centre , systematic prospective observational follow-up patient trigger GnRH agonist excessive follicular response conduct . Participants/materials , set , method : All patient undergoing antagonist protocol high risk OHSS ( estradiol level ≥ 3000 pg/mL and/or 20 follicle ≥ 11mm day trigger ) trigger GnRH agonist . No luteal phase support `` freeze-all '' strategy perform . On day oocyte retrieval ( T0 ) , 48h ( T1 ) day 7 ( T2 ) , OHSS hypercoagulability systematically assess . Haemostasis data compare initial status patient .</brief_summary>
	<brief_title>Ovarian Hyperstimulation Syndrome Patients Triggered GnRH Agonist Excessive Follicular Response</brief_title>
	<detailed_description>Seventy-five patient require study .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Ovarian Hyperstimulation Syndrome</mesh_term>
	<mesh_term>Thrombophilia</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<criteria>estradiol level ≥ 3000 pg/mL and/or 20 follicle ≥ 11mm day trigger antagonist protocol agonist protocol health assurance estradiol level &lt; 3000 pg/mL le 20 follicle ≥ 11mm day trigger</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>43 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>GnRH agonist trigger</keyword>
</DOC>